Literature DB >> 27451878

Impaired outcome colitis-associated rectal cancer versus sporadic cancer.

Coen L Klos1, Bashar Safar1, Paul E Wise1, Steven R Hunt1, Matthew G Mutch1, Elisa H Birnbaum1, James W Fleshman1, Sekhar Dharmarajan2.   

Abstract

BACKGROUND: The surgical management of colitis-associated rectal cancer (CARC) is not well defined. This study determines outcomes after surgery for CARC compared with sporadic rectal cancer.
MATERIALS AND METHODS: This is a retrospective cohort study comparing 27 patients with CARC with 54 matched patients with sporadic cancer. Matching criteria included age, gender, neoadjuvant chemoradiation, and American Joint Committee on Cancer stage. Outcome measures were disease-free and overall survival, tumor characteristics, and postoperative morbidity.
RESULTS: Compared to those with sporadic rectal cancer, patients with CARC underwent proctocolectomy more frequently (21 [78%] versus 6 [22%] P < 0.001) and were more likely to have mucinous tumors (11 [40.7%] versus 12 [22.3%] P = 0.03). Overall 3-y survival was significantly reduced in CARC patients compared with patients with sporadic rectal cancer. Those with CARC undergoing segmental proctectomy only demonstrated reduced overall and disease-free survival compared to patients with sporadic rectal cancer and to colitis patients undergoing proctocolectomy (P = 0.002).
CONCLUSIONS: Patients with CARC undergoing proctectomy demonstrate reduced disease-free survival versus those undergoing proctocolectomy, and versus patients with sporadic rectal cancer undergoing proctectomy. These findings warrant further study and suggest that proctocolectomy should be considered the preferred surgical approach for CARC.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colitis; Inflammatory bowel disease; Proctectomy; Proctocolectomy; Rectal cancer

Mesh:

Year:  2016        PMID: 27451878     DOI: 10.1016/j.jss.2016.03.006

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  3 in total

1.  Temporal trend in inpatient mortality in inflammatory bowel disease-associated colorectal cancer vs non-inflammatory colorectal cancer: a nationwide retrospective study.

Authors:  Estefania Flores; Chimezie Mbachi; Ikechukwu Achebe; Jennifer Asotibe; Emmanuel Palomera-Tejeda; Ishaan Vohra; Victor Udechukwu; Vikram Kotwal
Journal:  Int J Colorectal Dis       Date:  2020-10-15       Impact factor: 2.571

2.  Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis.

Authors:  Yoon Dae Han; Mahdi Hussain Al Bandar; Audrius Dulskas; Min Soo Cho; Hyuk Hur; Byung Soh Min; Kang Young Lee; Nam Kyu Kim
Journal:  BMC Surg       Date:  2017-03-21       Impact factor: 2.102

3.  Colitis-Associated Colorectal Cancer in Patients with Inflammatory Bowel Diseases in a Tertiary Referral Center: A Propensity Score Matching Analysis.

Authors:  Kasper Maryńczak; Jakub Włodarczyk; Zofia Sabatowska; Adam Dziki; Łukasz Dziki; Marcin Włodarczyk
Journal:  J Clin Med       Date:  2022-02-07       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.